Challenging paradigms in lymphoma treatment

被引：6
作者：
Bendandi, M
Pileri, SA
Zinzani, PL
机构：
[1] Univ Navarra, Univ Clin, Dept Hematol, Pamplona 31008, Spain
[2] Univ Navarra, Univ Clin, Cell Therapy Area, Pamplona 31008, Spain
[3] Univ Bologna, Inst Haematol & Clin Oncol L&A Seragnoli, Chair Pathol Anat, Bologna, Italy
[4] Univ Bologna, Inst Haematol & Clin Oncol L&A Seragnoli, Unit Haematopatol, Bologna, Italy
[5] Univ Bologna, Inst Haematol & Clin Oncol L&A Seragnoli, Lymphoma Unit, Bologna, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷 / 05期
关键词：
lymphoma classification; lymphoma treatment;
D O I：
10.1093/annonc/mdh094
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：703 / 711
页数：9
相关论文
共 112 条
[1]   Involved-field radiotherapy for advanced Hodgkin's lymphoma [J].
Aleman, BMP ;
Raemaekers, JMM ;
Tirelli, U ;
Bortolus, R ;
van't Veer, MB ;
Lybeert, MLM ;
Keuning, JJ ;
Carde, P ;
Girinsky, T ;
van der Maazen, RWM ;
Tomsic, R ;
Vovk, M ;
van Hoof, A ;
Demeestere, G ;
Lugtenburg, PJ ;
Thomas, J ;
Schroyens, W ;
De Boeck, K ;
Baars, JW ;
Kluin-Nelemans, JC ;
Carrie, C ;
Aoudjhane, M ;
Bron, D ;
Eghbali, H ;
Smit, WGJM ;
Meerwaldt, JH ;
Hagenbeek, A ;
Pinna, A ;
Henry-Amar, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (24) :2396-2406
[2]   Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue - A study of 15 patients [J].
Bailey, EM ;
Ferry, JA ;
Harris, NL ;
Mihm, MC ;
Jacobson, JO ;
Duncan, LM .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (08) :1011-1023
[3]   REGRESSION OF PRIMARY GASTRIC LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID-TISSUE TYPE AFTER CURE OF HELICOBACTER-PYLORI INFECTION [J].
BAYERDORFFER, E ;
NEUBAUER, A ;
RUDOLPH, B ;
THIEDE, C ;
LEHN, N ;
EIDT, S ;
STOLTE, M .
LANCET, 1995, 345 (8965) :1591-1594
[4]  
Bendandi M, 2001, Expert Rev Anticancer Ther, V1, P65, DOI 10.1586/14737140.1.1.65
[5]   Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma [J].
Bendandi, M ;
Gocke, CD ;
Kobrin, CB ;
Benko, FA ;
Sternas, LA ;
Pennington, R ;
Watson, TM ;
Reynolds, CW ;
Gause, BL ;
Duffey, PL ;
Jaffe, ES ;
Creekmore, SP ;
Longo, DL ;
Kwak, LW .
NATURE MEDICINE, 1999, 5 (10) :1171-1177
[6]   New treatments for advanced Hodgkin's disease: An uphill fight beginning close to the top [J].
Canellos, GP .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) :607-609
[7]   Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma [J].
Carella, AM ;
Cavaliere, M ;
Lerma, E ;
Ferrara, R ;
Tedeschi, L ;
Romanelli, A ;
Vinci, M ;
Pinotti, G ;
Lambelet, P ;
Loni, C ;
Verdiani, S ;
De Stefano, F ;
Valbonesi, M ;
Corsetti, MT .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (23) :3918-3924
[8]  
Cavalli F, 2001, Hematology Am Soc Hematol Educ Program, P241
[9]   ABVD versus Stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial [J].
Chisesi, T ;
Federico, M ;
Levis, A ;
Deliliers, GL ;
Gobbi, PG ;
Santini, G ;
Luminari, S ;
Brugiatelli, M .
ANNALS OF ONCOLOGY, 2002, 13 :102-106
[10]   CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. [J].
Coiffier, B ;
Lepage, E ;
Brière, J ;
Herbrecht, R ;
Tilly, H ;
Bouabdallah, R ;
Morel, P ;
Van den Neste, E ;
Salles, G ;
Gaulard, P ;
Reyes, F ;
Gisselbrecht, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) :235-242
12345678910